ArticleFrontiers in aging neuroscience2025
Individualized diagnosis of Parkinson's disease based on multivariate magnetic resonance imaging radiomics and clinical indexes.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Support vector machine-driven Parkinson's disease identification: a 7-Tesla multidimensional structural MRI approach.NPJ Parkinson's disease · 2026Article
- Quantitative susceptibility mapping and MRS-based multimodal machine learning for early Parkinson's disease classification.NPJ Parkinson's disease · 2026Article
- Magnetic resonance imaging in Parkinson's disease: from routine imaging to molecular biomarkers - an update for radiologists.Polish journal of radiology · 2026Review
- Multimodal MRI Radiomics and Machine Learning Identify Node-Level Structural and Functional Alterations in HIV-Associated Asymptomatic Neurocognitive Impairment.Neuropsychiatric disease and treatment · 2026Article
- The Evolving Global Burden of Young-Onset Parkinson's Disease (1990-2021): Regional, Gender, and Age Disparities in the Context of Rising Incidence and Declining Mortality.Brain and behavior · 2025Article
- Leveraging object detection for early diagnosis of neurodegenerative diseases through radiomic analysis.Frontiers in aging neuroscience · 2025Article
- Combined with multimodal medical imaging and artificial intelligence for early diagnosis of Parkinson's disease.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore MRI-based radiomics models, integrating clinical characteristics, for differential diagnosis of Parkinson's disease (PD) to evaluate their diagnostic performance. Methods: A total of 256 participants [153 PD, 103 healthy controls (HCs)] from the First Affiliated Hospital of Wenzhou Medical Hospital, were enrolled as the training set, and 120 subjects (74 PD, 46 HCs) from the PPMI dataset served as the test set. Radiomics features were extracted from structural MRI (T1WI and T2-FLair). Support Vector Machine (SVM) classifiers were developed using MRI radiomics data from both monomodal and multimodal radiomics models. The clinical-radiomics model was constructed by integrating clinical variables, including UPDRS, Hoehn-Yahr stage, age, sex, and MMSE scores. Receiver operating characteristic (ROC) curves were generated to evaluate the performance of the models. Decision curve analysis (DCA) was performed to access the clinical usefulness of the models. Results: In the training set, the T2-FLair and T1WI radiomics model achieved an AUC of 0.896 (95% CI, 0.812-0.900) and 0.899 (95% CI, 0.818-0.908), respectively. The double-sequence radiomics model demonstrated superior diagnostic performance, with an AUC of 0.965 (95% CI, 0.885-0.978) in the training set and an AUC of 0.852 (95% CI, 0.748-0.910) in the test set. The integrated clinical-radiomics model showed enhanced diagnostic accuracy, with AUC = 0.983 (95% CI, 0.897-0.996) in the training set and AUC = 0.837 (95% CI, 0.786-0.902) in the test set. Rad-scores derived from the radiomics model were significantly correlated with diagnostic outcomes ( Conclusion: The integrated clinical-radiomics model offered superior diagnostic performance compared to models based relying solely on imaging or clinical data, underscoring its potential as a non-invasive and effective tool in routine clinical practice for the early diagnosis of PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.